Tagrisso

Film-coated tablet, 40mg
RxActive license

Active substance (INN)

osimertinib

Pharmaceutical form

Pharmaceutical formFilm-coated tablet
Strength40mg
PackagingUkupno 30 film tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerAstraZeneca AB, Sweden
Therapeutic groupAntineoplastic and immunomodulating agents (L01EB04)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateSeptember 5, 2019

Analogs in Montenegro

1

Other medicines with the same active substance

TagrissoRx
Film-coated tablet, 80mgAstraZeneca AB
Source: CInMED register